CBRE GROUP, INC.

CBRE

CIK 0001138118 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$10.53B
↑+18.6% +$1.65Bvs FY2025 (Q1)
Operating Income
$511M
↑+85.1% +$235Mvs FY2025 (Q1)
Net Income
$318M
↑+95.1% +$155Mvs FY2025 (Q1)
Gross Profit
$1.85B
↑+15.0% +$242Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
62/100
  • Profitability
    28ROIC 10.7% (10% = solid, 20%+ = moat)
  • Liquidity
    30Current Ratio 1.09 (above 1.5 = solid)
  • Leverage
    72D/E 0.57 (under 0.5 = conservative)
  • Efficiency
    98Asset Turnover 1.47x (1.0+ = capital-efficient)
  • Growth
    79Revenue YoY +18.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    62Op Margin 4.9% · trend +0.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CBRE's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -4.5%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$55.38
Total enterprise IV
$16.65B
Diluted shares
0.30B
Terminal PV
$11.74B (70% of total)
Year-5 FCF
$1.38B
YearProjected FCFDiscounted PV
+1$1.23B$1.12B
+2$1.27B$1.05B
+3$1.30B$979M
+4$1.34B$917M
+5$1.38B$859M
Terminal$18.90B$11.74B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$383M
investment in PP&E
Stock buybacks (TTM)
$1.08B
share count reduction
Stock-based comp (TTM)
$147M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$30.17B
everything owned
Total liabilities
$20.86B
everything owed
Stockholders' equity
$8.52B
shareholder claim
Net debt
$3.36B
LT debt minus cash

Recent performance · 68 quarters

Revenue↑+18.6% +$1.65B
$10.53B
Net Income↑+95.1% +$155M
$318M
Free Cash Flow↓-48.5% -$296M
$-906M
Operating Margin↑+1.7pts
4.9%

Drill down